Biblio

Export 3284 results:
Author Title Type [ Year(Desc)]
Filters: Filter is   [Clear All Filters]
2025
M. A. Thorwald, Maria, N. S. Sta, Chakhoyan, A., O'Day, P. A., Jacobs, R. E., Zlokovic, B., and Finch, C. E., Iron chelation by oral deferoxamine treatment decreased brain iron and iron signaling proteins., J Alzheimers Dis, p. 13872877241313031, 2025.
E. L. Thacker, Karki, R., Gabor, R., Blades, N. J., Sawyer, R. P., Beckodro, C. N. Kouambo, Preece, Q., Prince, S., Smith, M. K. M., Gillett, S. R., Judd, S. E., Kennedy, R. E., Kizer, J. R., Levine, D. A., McClellan, W. M., Tamura, M. Kurella, Unverzagt, F. W., Wadley, V. G., and Cushman, M., Leptin, adiponectin, body mass index, and incident cognitive impairment., J Alzheimers Dis, p. 13872877251326060, 2025.
H. Roberts, Fang, Y., Quinn, K., Hill, T., Peck, M. R., Bartke, A., Hascup, K. N., and Hascup, E. R., Lifespan of male and female APP/PS1 and APP mouse models of Alzheimer's disease., J Alzheimers Dis, p. 13872877251325878, 2025.
S. Gui, Zeng, F., Wu, Z., Nonaka, S., Sano, T., Ni, J., Nakanishi, H., Moriyama, M., and Kanematsu, T., Lipopolysaccharides from indirectly induce neuronal GSK3β-dependent synaptic defects and cause cognitive decline in a low-amyloid-β-concentration environment in Alzheimer's disease., J Alzheimers Dis, p. 13872877251326879, 2025.
P. Grau-Jurado, Mostafaei, S., Xu, H., Mo, M., Petek, B., Kalar, I., Naia, L., Kele, J., Maioli, S., Pereira, J. B., Eriksdotter, M., Chatterjee, S., and Garcia-Ptacek, S., Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients., J Alzheimers Dis, p. 13872877241307870, 2025.
D. A. Levine, Sussman, J. B., Hayward, R. A., Gałecki, A. T., Whitney, R. T., Briceño, E. M., Gross, A. L., Giordani, B. J., Elkind, M. Sv, Gottesman, R. F., Gaskin, D. J., Sidney, S., Yaffe, K., and Burke, J. F., The potential impact of optimal blood pressure treatment intensity to reduce disparities in dementia between Black and White individuals., J Alzheimers Dis, p. 13872877241302506, 2025.
Y. Zhai, Lu, K., Yuan, Y., Zhang, Z., Xue, L., Zhao, F., Xu, X., and Wang, H., Semaglutide improves cognitive function and neuroinflammation in APP/PS1 transgenic mice by activating AMPK and inhibiting TLR4/NF-κB pathway., J Alzheimers Dis, p. 13872877251329439, 2025.
C. Hyun Park, Lee, H., Lee, Y. - M., Lee, B. - D., Moon, E., Suh, H., Kim, K., Kim, H. - J., Shim, H., Pak, K., Choi, K. - U., and Kim, C. - S., Sex-specific effects of apolipoprotein E ε4 genotype on longitudinal hippocampal atrophy in amnestic mild cognitive impairment over a 2-year evaluation period., J Alzheimers Dis, p. 13872877241313066, 2025.
H. Kasahara, Ikeda, M., Makioka, K., Nakamura, T., Takahashi, R., Kawarabayashi, T., Sanada, E., Suto, T., Higuchi, T., Tsushima, Y., and Ikeda, Y., White matter lesions rather than amyloid-β burden are associated with cognitive decline in Alzheimer's disease., J Alzheimers Dis, p. 13872877251316516, 2025.

Pages